Zusammenfassung
Blasenbildende Autoimmundermatosen sind meist schwer und chronisch verlaufende Erkrankungen der Haut und Schleimhäute, die selten auch bei Kindern auftreten. Zugrunde liegt eine Spaltbildung in der dermoepidermalen Junktionszone oder innerhalb der Epidermis, die meist durch gegen Adhäsionsstrukturen der Haut gerichtete zirkulierende Autoantikörper hervorgerufen wird. Die im Kindesalter häufigste dieser Erkrankungen ist die lineare IgA-Dermatose; Pemphigoid- und Pemphiguserkrankungen, Epidermolysis bullosa acquisita und Dermatitis herpetiformis treten demgegenüber deutlich seltener auf. Häufiger als im Erwachsenalter sind bei Kindern Schleimhäute beteiligt. In den letzten Jahren ist die Identifikation der meisten der zugrunde liegenden Autoantigene gelungen. Dies hat zu einer Verbesserung der Diagnostik geführt und erleichtert Therapieentscheidungen. Zur Behandlung ist in der Regel eine systemische Immunsuppression erforderlich. Angesichts des häufig langjährigen und mitunter komplizierten Verlaufs blasenbildender Autoimmundermatosen ist eine enge Zusammenarbeit zwischen Dermatologen und Pädiatern anzustreben.
Abstract
Autoimmune blistering skin diseases are exceedingly rare in children. In most cases, they are characterized by circulating autoantibodies directed against adhesion structures of the skin which subsequently induce blistering at the dermoepidermal junction or intraepidermally. The most frequent paediatric immunobullous disease is linear IgA dermatosis; all others such as pemphigoid, epidermolysis bullosa acquisita, dermatitis herpetiformis and pemphigus are less common than in adults. In children, mucous membranes are involved more frequently. Recent advances in the identification of the autoantigens have improved diagnostic approach and therapeutic management of blistering diseases. In most cases, treatment requires systemic immunosuppression. With respect to the chronic course of the diseases and potential complications of treatment, cooperation between dermatologists and paediatricians seems advisable.
Literatur
Weston WL, Morelli JG, Huff JC (1997) Misdiagnosis, treatments and outcomes in the immunobullous diseases in children. Ped Dermatol 14:264-272
Zillikens D (1999) Erworbene bullöse Dermatosen. In: Traupe H, Hamm H (Hrsg) Pädiatrische Dermatologie. Springer, Berlin Heidelberg New York Tokyo, S 593-603
Chorzelski TP, Jablonska S (1979) IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 101:535-542
Collier PM, Wojnarowska F (1993) Linear IgA disease and chronic bullous disease of childhood. Eur J Dermatol 3:623-634
Egan CA, Zone JJ (1999) Linear IgA bullous dermatitis. Int J Dermatol 38:818-827
Powell J, Kirtschig G, Allen J et al. (2001) Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol 144:769-774
Rabinowitz LG, Esterly NB (1993) Inflammatory bullous diseases in children. Dermatol Clin 11:565-581
Nemeth AJ, Klein AD, Gould EW, Schachner LA (1991) Childhood bullous pemphigoid. Arch Dermatol 127:368-386
Oranje AP, van Joost T (1989) Pemphigoid in children. Pediatr Dermatol 6:267-274
Rico MJ (1995) Autoimmune blistering diseases in children. Semin Dermatol 14:54-59
Farrell AM, Kirtschig G, Dalziel KL et al. (1999) Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 140:308-312
Chimanovitch I, Hamm H, Georgi M et al. (2000) Bullous pemphigoid of childhood. Autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood. Arch Dermatol 136:527-532
Wojnarowska F, Marsden RA, Bhogal B, Black MM (1988) Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 19:792-805
Wojnarowska F, Kirtschig G, Khumalo N (2001) Treatment of subepidermal immunobullous disease. Clin Dermatol 19:768-777
Chimanovitch I, Bröcker EB, Zillikens D (2001) Pemphigoid (Herpes) gestationis: Neue Aspekte zur Pathogenese und Diagnostik. Geburtsh Frauenheilk 61:250-256
Arpey CJ, Elewski BE, Moritz DK, Gammon WR (1991) Childhood epidermolysis bullosa acquisita. Report of three cases and review of the literature. J Am Acad Dermatol 24:706-714
Callot-Mellot C, Bodemer C, Caux F et al. (1997) Epidermolysis bullosa acquisita in childhood. Arch Dermatol 133:1122-1126
Schmidt E, Höpfner B, Chen M et al. (2002) Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 147:592-597
Tanaka H, Ishida-Yamamoto A, Hashimoto T et al. (1997) A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 77:623-632
Shirahama S, Furukawa F, Yagi H et al. (1998) Bullous systemic lupus erthematosus: detection of antibodies against noncollagenous domain of type VII collagen. J Am Acad Dermatol 38:844-848
Ermacora E, Prampolini L, Tribbia G et al. (1986) Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol 15:24-30
McGovern TW, Bennion SD (1994) Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis. Pediatr Dermatol 11:319-322
Schuppan D (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119:234-242
Bjarnason B, Flosadóttir E (1999) Childhood, neonatal and stillborn pemphigus vulgaris. Int J Dermatol 38:680-688
Wananukul S, Pongprasit P (1999) Childhood pemphigus. Int J Dermatol 38:29-35
Mehravaran M, Morvay M, Molnár K et al. (1998) Juvenile pemphigus foliaceus. Br J Dermatol 139:496-499
Wu H, Wang ZH, Yan A et al. (2000) Protection against pemphigus foliaceus by desmoglein 3 in neonates. New Engl J Med 343:31-35
Campo-Voegeli A, Muniz F, Mascaró JM et al. (2002) Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. Br J Dermatol 147:801-805
Mimouni D, Anhalt GJ, Lazarova Z et al. (2002) Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 147:725-732
Borradori L, Lombardi T, Samson J et al. (2001) Anti-CD20 monoclonal antibody (rituximab) for refractory stomatitis secondary to CD20+ follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 137:269-272
Danksagung
Die Autoren danken Dr. Cassian Sitaru und Dr. Christian Rose, Würzburg, Dr. Thomas Wygold, Lübeck, sowie Professor Dr. Lutz Weber, Ulm, für die Bereitstellung von Abbildungsmaterial.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goebeler, M., Zillikens, D. Bullöse Autoimmunerkrankungen des Kindesalters. Hautarzt 54, 14–24 (2003). https://doi.org/10.1007/s00105-002-0466-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-002-0466-1
Schlüsselwörter
- Bullöse Autoimmundermatosen des Kindesalters
- Lineare IgA-Dermatose
- Pemphigoid
- Dermatitis herpetiformis
- Pemphigus